SCHEMBL4443409

SCHEMBL4443409

CCCC[C](C(C)C)C(C)(CCC)C(C)CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10932081 0.76
SCHEMBL5783006 0.76 CES2 (0.32)
SCHEMBL8852307 0.69
SCHEMBL12113778 0.68 CA2 (0.34)
SCHEMBL31347875 0.63 CA2 (0.32)
SCHEMBL23907061 0.63 MMP8 (0.41)
SCHEMBL6328800 0.63
SCHEMBL6881191 0.63 CES2 (0.31)
SCHEMBL7955527 0.62 CES1 (0.43)
SCHEMBL9489613 0.62 FDPS (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006781-A1 ESTROGEN RECEPTOR ALPHA DEGRADERS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-01-04 WO disclosed
WO-2022261069-A1 METHODS AND TREATMENT OF VIRAL INFECTION WITH SUBSTITUTED PYRAZOLO-PYRIMIDINES Verge Analytics, Inc. (US) 2022-12-15 WO disclosed
US-20090074757-A1 Antitumor Combination Comprising Substituted Acryloyl Distamycin Derivatives and Antibodies Inhibiting Growth Factors or Their Receptors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-03-19 US disclosed
US-20050272745-A1 Novel piperidine and piperazine derivatives ASTRAZENECA AB 2005-12-08 US disclosed